Search research articles
Contact Us
Filters
Showing results (81-90 of 112) with videos related to
Page
of 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 28, 2015
Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials
Massimo Di Maio, Ciro Gallo, Natasha B Leighl, et al.
Journal of the National Cancer Institute
|
March 6, 2003
Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial
Cesare Gridelli, Francesco Perrone, Ciro Gallo, et al.
Critical Reviews in Oncology/Hematology
|
August 19, 2006
Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly. A study of the Cancer of the Liver Italian Program (CLIP)
Sandro Pignata, Ciro Gallo, Bruno Daniele, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 7, 2013
Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: the CAPPA-2 study
Alessandro Morabito, Vittorio Gebbia, Massimo Di Maio, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
October 23, 2020
A qualitative analysis and development of a conceptual model assessing financial toxicity in cancer patients accessing the universal healthcare system
Silvia Riva, Fabio Efficace, Massimo Di Maio, et al.
The Lancet. Oncology
|
April 18, 2015
Pazopanib plus weekly paclitaxel versus weekly paclitaxel alone for platinum-resistant or platinum-refractory advanced ovarian cancer (MITO 11): a randomised, open-label, phase 2 trial
Sandro Pignata, Domenica Lorusso, Giovanni Scambia, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 3, 2021
Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer - A GISCAD phase II randomized trial
Stefano Cascinu, Rossana Berardi, Roberto Bianco, et al.
Frontiers in Medicine
|
December 26, 2022
A multicenter randomized phase 4 trial comparing sodium picosulphate plus magnesium citrate vs. polyethylene glycol plus ascorbic acid for bowel preparation before colonoscopy. The PRECOL trial
Valentina D'Angelo, Maria Carmela Piccirillo, Massimo Di Maio, et al.
JAMA Network Open
|
July 26, 2021
Effect of Bevacizumab in Combination With Standard Oxaliplatin-Based Regimens in Patients With Metastatic Colorectal Cancer: A Randomized Clinical Trial
Antonio Avallone, Maria C Piccirillo, Guglielmo Nasti, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 3, 2012
Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trials
Massimo Di Maio, Simona Signoriello, Alessandro Morabito, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 112) with videos related to
Sort By:
Page
of 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 28, 2015
Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials
Massimo Di Maio, Ciro Gallo, Natasha B Leighl, et al.
Journal of the National Cancer Institute
|
March 6, 2003
Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial
Cesare Gridelli, Francesco Perrone, Ciro Gallo, et al.
Critical Reviews in Oncology/Hematology
|
August 19, 2006
Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly. A study of the Cancer of the Liver Italian Program (CLIP)
Sandro Pignata, Ciro Gallo, Bruno Daniele, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 7, 2013
Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: the CAPPA-2 study
Alessandro Morabito, Vittorio Gebbia, Massimo Di Maio, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
October 23, 2020
A qualitative analysis and development of a conceptual model assessing financial toxicity in cancer patients accessing the universal healthcare system
Silvia Riva, Fabio Efficace, Massimo Di Maio, et al.
The Lancet. Oncology
|
April 18, 2015
Pazopanib plus weekly paclitaxel versus weekly paclitaxel alone for platinum-resistant or platinum-refractory advanced ovarian cancer (MITO 11): a randomised, open-label, phase 2 trial
Sandro Pignata, Domenica Lorusso, Giovanni Scambia, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 3, 2021
Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer - A GISCAD phase II randomized trial
Stefano Cascinu, Rossana Berardi, Roberto Bianco, et al.
Frontiers in Medicine
|
December 26, 2022
A multicenter randomized phase 4 trial comparing sodium picosulphate plus magnesium citrate vs. polyethylene glycol plus ascorbic acid for bowel preparation before colonoscopy. The PRECOL trial
Valentina D'Angelo, Maria Carmela Piccirillo, Massimo Di Maio, et al.
JAMA Network Open
|
July 26, 2021
Effect of Bevacizumab in Combination With Standard Oxaliplatin-Based Regimens in Patients With Metastatic Colorectal Cancer: A Randomized Clinical Trial
Antonio Avallone, Maria C Piccirillo, Guglielmo Nasti, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 3, 2012
Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trials
Massimo Di Maio, Simona Signoriello, Alessandro Morabito, et al.
Page
of 12